Ulysses Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Ulysses Management's EW Position: Q2 2026 in Review
Ulysses Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 5,000 shares worth $452K. The stake represents 0.09% of the portfolio and ranks #40 among its holdings. This is a return to the name: Ulysses Management previously reported a position in EW as recently as Q1 2024.
Ulysses Management first reported a position in EW in Q1 2024 and has held it in 2 quarters since. The position peaked at $669K in Q1 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Ulysses Management held 5,000 shares of Edwards Lifesciences worth $452K as of Q2 2026.
- Edwards Lifesciences was a new Ulysses Management position in Q2 2026.
- Edwards Lifesciences made up 0.09% of Ulysses Management's portfolio in Q2 2026, its #40 holding.
- Ulysses Management first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 2 quarters since.
- Ulysses Management's Edwards Lifesciences position peaked at $669K in Q1 2024.
- 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Ulysses Management's 13F filing for Q2 2026, filed 14 Aug 2026.